Individual Study / LGP

Longevity Gene Project (LGP)

Longevity Gene Project (LGP)

Initiatives -
Lead to new drug therapies that might help people live longer, healthier lives and avoid or significantly delay age-related diseases such as Alzheimer's disease, type 2 diabetes and cardiovascular disease.
Funding
National Institute of Aging and the Glenn Foundation
Visit LGP

Members

Download
Investigators Contacts
  • Dr. Nir Barzilai
    Albert Einstein - College of Medicine

Design

Study design
Population cohort

Marker Paper

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
500
Number of participants with biosamples
Supplementary Information
Elderly people between the ages of 95 and 112 and on their children.

Access

Availability of data and biosamples

Data
Biosamples
Other